Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $633.10 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $451.86 | 17 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $108.80 | 6 | $0 (2019) |
| Lundbeck LLC | $39.13 | 2 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $18.67 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $14.64 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $284.05 | 10 | Allergan Inc. ($184.62) |
| 2018 | $76.98 | 6 | Allergan Inc. ($63.70) |
| 2017 | $272.07 | 12 | Allergan Inc. ($203.54) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: PSYCHIATRY | ||||||
| 02/19/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: PSYCHIATRY | ||||||
| 07/12/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.64 | General |
| 06/26/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PSYCHIATRY | ||||||
| 04/26/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $98.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 34 | 369 | $41,560 | $25,719 |
| 2020 | 2 | 34 | 252 | $24,248 | $17,139 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 17 | 183 | $26,117 | $15,729 | 60.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 186 | $15,443 | $9,989 | 64.7% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 16 | 124 | $15,474 | $10,974 | 70.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 128 | $8,774 | $6,165 | 70.3% |
About Dr. Mayer Weinstein, MD
Dr. Mayer Weinstein, MD is a Psychiatry healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841390101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mayer Weinstein, MD has received a total of $633.10 in payments from pharmaceutical and medical device companies, with $284.05 received in 2019. These payments were reported across 28 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($633.10).
As a Medicare-enrolled provider, Weinstein has provided services to 68 Medicare beneficiaries, totaling 621 services with total Medicare billing of $42,857. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Portland, OR
- Active Since 09/25/2006
- Last Updated 10/07/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841390101
Products in Payments
- VRAYLAR (Drug) $318.15
- REXULTI (Drug) $147.93
- NAMZARIC (Drug) $133.71
- Trintellix (Drug) $18.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Portland
Dr. Alisha Moreland, M.d, M.D
Psychiatry — Payments: $20,000
Glenn Currier, Md, MD
Psychiatry — Payments: $10,833
Dr. Jonathan Horey, M.d, M.D
Psychiatry — Payments: $7,457
Samir Ishak, Md, MD
Psychiatry — Payments: $6,005
Nancy Phillips, Md, MD
Psychiatry — Payments: $4,944
Alfred Lewy, Md, MD
Psychiatry — Payments: $4,458